Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019

YTD

ALL

Why Robinhood?

You can watch ONSIW and buy or sell other stocks, ETFs, and their options commission-free!

About ONSIW

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.

CEO

Robert Charles Jahr, MBA

CEORobert Charles Jahr, MBA

Employees

—

Employees—

Headquarters

Iselin, New Jersey

HeadquartersIselin, New Jersey

Founded

2010

Founded2010

Employees

—

Employees—

ONSIW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.